ESTUDO SOBRE O PROCESSO CORROSIVO E A MANUTENÇÃO EMPREGADA NO MISTURADOR DA PRODUÇÃO INDUSTRIAL DE CERÂMICA VERMELHA EM CAMPOS DOS GOYTACAZES

O presente trabalho estuda o processo de corrosão nos misturadores empregados no processamento da argila, tendo como foco as empresas ceramistas do município de Campos dos Goytacazes. Os equipamentos deste tipo em geral são metálicos, de aço carbono, tipo muito susceptível ao ataque corrosivo. Discute-se os diferentes tipos de corrosão e como os problemas gerados devido a este processo, podem ser solucionados/minimizados. Foi realizado junto a 8 empresas ceramistas do município um levantamento dos principais problemas identificados no cotidiano do processo de produção da cerâmica vermelha. São apresentados também os diferentes tipos e características dos processos de prevenção, isto é, as formas de manutenção. Considera-se que a manutenção preventiva seja muito eficiente para uma redução significativa dos gastos das empresas

French ichthyological records for 2019

WOS:000715836000001International audienceUncommon fish records may reflect local or global changes of fish composition resulting from environmental changes or anthropog,enic activities. Significant records of uncommon marine fishes, including migrant, non-native, cryptic, rare and threatened species, collected in French waters or by French vessels in European waters, observed by scuba divers or beachgoers, are reported for the year 2019. They include first, new, rare and unusual records for the following 33 species: Tetronarce nobiliana, Gymnothorax unicolor, Maulisia mauli, Salmo trutta, Grammonus aler, Photostomias guernei, Ifintaia loppei, Echiodon drummondii, Holocentrus adscensionis, Nerophis lumbriciformis, Scorpaena scrofa, Lepidoirigla dieuzeidei, Eutelichthys leptochirus, Liparis montag tti, Mycteroperca rubra, Serranus cabrilla, Remora remora, Caram: crysos, Naucrates doctor, Trachurus picturatus, Seriola rivoliana, Argyrosomus regius, Parablennius pilicornis, Pseudoscopelus astronesthidens, Deltentosteus collonianus, Didogobius schlieweni, Didogobius splechinai, Gobius couchi, Gobius f.;asteveni, Lebetus guilleti, Synapturichthys kleinii, Lagocephalus lagocephalus and 21.1ola mola, among which I. loppei, H. adscensionis and P. astronesthidens represent first records for the French waters and additions to the Checklist of the marine fishes from metropolitan France. Photostomias guernei is a first record for the Bay of Biscay, found close the French ETV,

A phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants.

\ud \ud The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial. We administered RTS,S/AS01 or a comparator vaccine to 6537 infants who were 6 to 12 weeks of age at the time of the first vaccination in conjunction with Expanded Program on Immunization (EPI) vaccines in a three-dose monthly schedule. Vaccine efficacy against the first or only episode of clinical malaria during the 12 months after vaccination, a coprimary end point, was analyzed with the use of Cox regression. Vaccine efficacy against all malaria episodes, vaccine efficacy against severe malaria, safety, and immunogenicity were also assessed. The incidence of the first or only episode of clinical malaria in the intention-to-treat population during the 14 months after the first dose of vaccine was 0.31 per person-year in the RTS,S/AS01 group and 0.40 per person-year in the control group, for a vaccine efficacy of 30.1% (95% confidence interval [CI], 23.6 to 36.1). Vaccine efficacy in the per-protocol population was 31.3% (97.5% CI, 23.6 to 38.3). Vaccine efficacy against severe malaria was 26.0% (95% CI, -7.4 to 48.6) in the intention-to-treat population and 36.6% (95% CI, 4.6 to 57.7) in the per-protocol population. Serious adverse events occurred with a similar frequency in the two study groups. One month after administration of the third dose of RTS,S/AS01, 99.7% of children were positive for anti-circumsporozoite antibodies, with a geometric mean titer of 209 EU per milliliter (95% CI, 197 to 222). The RTS,S/AS01 vaccine coadministered with EPI vaccines provided modest protection against both clinical and severe malaria in young infants. (Funded by GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative; RTS,S ClinicalTrials.gov number, NCT00866619.)

Reproducibility of fluorescent expression from engineered biological constructs in E. coli

We present results of the first large-scale interlaboratory study carried out in synthetic biology, as part of the 2014 and 2015 International Genetically Engineered Machine (iGEM) competitions. Participants at 88 institutions around the world measured fluorescence from three engineered constitutive constructs in E. coli. Few participants were able to measure absolute fluorescence, so data was analyzed in terms of ratios. Precision was strongly related to fluorescent strength, ranging from 1.54-fold standard deviation for the ratio between strong promoters to 5.75-fold for the ratio between the strongest and weakest promoter, and while host strain did not affect expression ratios, choice of instrument did. This result shows that high quantitative precision and reproducibility of results is possible, while at the same time indicating areas needing improved laboratory practices.Peer reviewe